Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Tirzepatide is a medication originally developed to treat type 2 diabetes, which has also shown outstanding potential in assisting patients with weight management
Semaglutide-based program: $425/month Tirzepatide-based program: $425/month Your monthly program includes: Online medical evaluation and follow-up care Physician-guided program oversight Compounded medications incorporated into the program when prescribed Optional discreet delivery through a licensed 503B pharmacy Ongoing progress monitoring and provider support Program adjustments as appropriate over time Flexible Payment Options and Patient Support We understand that starting a medical weight loss program is an investment, which is why InjectCo offers financing options through Cherry and CareCredit
Increased body weight: Various animal studies have linked ipamorelin to body weight gain [8, 9]
2,2 ng/mL or 4,8 nmol/L) and red blood cells (i.e
No user database
US$ 27.82
US$ 29.44
US$ 21.86
US$ 22.43
US$ 24.29
US$ 29.34
